Harmen Reyngoudt1,2, Benjamin Marty1,2, Ericky Caldas de Almeida Araújo1,2, Pierre-Yves Baudin3, Julien Le Louër1,2, Jean-Marc Boisserie1,2, Anthony Béhin4, Laurent Servais5,6,7,8, Teresa Gidaro5,6, Pierre G Carlier1,2. 1. NMR Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France. 2. NMR Laboratory, CEA, DRF, IBFJ, MIRCen, Paris, France. 3. Consultants for Research in Imaging and Spectroscopy (C.R.I.S.), Tournai, Belgium. 4. Neuromuscular Reference Center, Institute of Myology, Pitié-Salpêtrière Hospital (AP-HP), Paris, France. 5. Institute of Myology, Pitié-Salpêtrière Hospital (AP-HP), Paris, France. 6. I-Motion-Pediatric Clinical Trials Department, Trousseau Hospital (AP-HP), Paris, France. 7. Centre de référence des maladies Neuromusculaires, CHU, University of Liège, Liège, Belgium. 8. MDUK Oxford Neuromuscular Center, Department of Pediatrics, University of Oxford, Oxford, UK.
Abstract
BACKGROUND: Quantitative nuclear magnetic resonance imaging (NMRI) is an objective and precise outcome measure for evaluating disease progression in neuromuscular disorders. We aimed to investigate predictive 'disease activity' NMR indices, including water T2 and 31P NMR spectroscopy (NMRS), and its relation to NMR markers of 'disease progression', such as the changes in fat fraction (ΔFat%) and contractile cross-sectional area (ΔcCSA), in GNE myopathy (GNEM) patients. METHODS: NMR was performed on a 3T clinical scanner, at baseline and at a 1-year interval, in 10 GNEM patients and 29 age-matched controls. Dixon-based fat-water imaging and water T2 mapping were acquired in legs and thighs, and in the dominant forearm. 31P NMRS was performed at the level of quadriceps and hamstring. Water T2 and 31P NMRS indices were determined for all muscle groups and visits. Correlations were performed with 'disease progression' indices ΔFat%, ΔcCSA and the muscle fat transformation rate (Rmuscle_transf). RESULTS: In quadriceps, known to be relatively preserved in GNEM, water T2 at baseline was significantly higher compared to controls, and correlated strongly with the one-year evolution of Fat% and cCSA and Rmuscle_transf. Various 31P NMRS indices showed significant differences in quadriceps and hamstring compared to controls and correlations existed between these indices and ΔFat%, ΔcCSA and Rmuscle_transf. CONCLUSIONS: This study demonstrates that disease activity indices such as water T2 and 31P NMRS may predict disease progression in skeletal muscles of GNEM patients, and suggests that these measures may be considered to be valuable surrogate endpoints in the assessment of GNEM disease progression. 2020 Quantitative Imaging in Medicine and Surgery. All rights reserved.
BACKGROUND: Quantitative nuclear magnetic resonance imaging (NMRI) is an objective and precise outcome measure for evaluating disease progression in neuromuscular disorders. We aimed to investigate predictive 'disease activity' NMR indices, including water T2 and 31P NMR spectroscopy (NMRS), and its relation to NMR markers of 'disease progression', such as the changes in fat fraction (ΔFat%) and contractile cross-sectional area (ΔcCSA), in GNE myopathy (GNEM) patients. METHODS: NMR was performed on a 3T clinical scanner, at baseline and at a 1-year interval, in 10 GNEM patients and 29 age-matched controls. Dixon-based fat-water imaging and water T2 mapping were acquired in legs and thighs, and in the dominant forearm. 31P NMRS was performed at the level of quadriceps and hamstring. Water T2 and 31P NMRS indices were determined for all muscle groups and visits. Correlations were performed with 'disease progression' indices ΔFat%, ΔcCSA and the muscle fat transformation rate (Rmuscle_transf). RESULTS: In quadriceps, known to be relatively preserved in GNEM, water T2 at baseline was significantly higher compared to controls, and correlated strongly with the one-year evolution of Fat% and cCSA and Rmuscle_transf. Various 31P NMRS indices showed significant differences in quadriceps and hamstring compared to controls and correlations existed between these indices and ΔFat%, ΔcCSA and Rmuscle_transf. CONCLUSIONS: This study demonstrates that disease activity indices such as water T2 and 31P NMRS may predict disease progression in skeletal muscles of GNEM patients, and suggests that these measures may be considered to be valuable surrogate endpoints in the assessment of GNEM disease progression. 2020 Quantitative Imaging in Medicine and Surgery. All rights reserved.
Entities:
Keywords:
31P nuclear magnetic resonance spectroscopy (31P NMRS); GNE myopathy (GNEM); quantitative nuclear magnetic resonance imaging (quantitative NMRI); skeletal muscle; water T2
Authors: Hermien E Kan; Tom W J Scheenen; Marielle Wohlgemuth; Dennis W J Klomp; Ivonne van Loosbroek-Wagenmans; George W Padberg; Arend Heerschap Journal: Neuromuscul Disord Date: 2009-03-28 Impact factor: 4.296
Authors: John Karl L de Dios; Joseph A Shrader; Galen O Joe; Jeffrey C McClean; Kayla Williams; Robert Evers; May Christine V Malicdan; Carla Ciccone; Ami Mankodi; Marjan Huizing; John C McKew; David A Bluemke; William A Gahl; Nuria Carrillo-Carrasco Journal: Neuromuscul Disord Date: 2014-08-07 Impact factor: 4.296
Authors: Alina Sprenger-Svačina; Johannes Haensch; Kilian Weiss; Nils Große Hokamp; David Maintz; Marc Schlamann; Gereon R Fink; Natalie Schloss; Kai Laukamp; Gilbert Wunderlich; Helmar C Lehmann; Thorsten Lichtenstein Journal: J Neurol Date: 2022-10-01 Impact factor: 6.682
Authors: Thom T J Veeger; Nienke M van de Velde; Kevin R Keene; Erik H Niks; Melissa T Hooijmans; Andrew G Webb; Jurriaan H de Groot; Hermien E Kan Journal: NMR Biomed Date: 2022-02-05 Impact factor: 4.478
Authors: Harmen Reyngoudt; Fiona E Smith; Ericky Caldas de Almeida Araújo; Ian Wilson; Roberto Fernández-Torrón; Meredith K James; Ursula R Moore; Jordi Díaz-Manera; Benjamin Marty; Noura Azzabou; Heather Gordish; Laura Rufibach; Tim Hodgson; Dorothy Wallace; Louise Ward; Jean-Marc Boisserie; Julien Le Louër; Heather Hilsden; Helen Sutherland; Aurélie Canal; Jean-Yves Hogrel; Marni Jacobs; Tanya Stojkovic; Kate Bushby; Anna Mayhew; Volker Straub; Pierre G Carlier; Andrew M Blamire Journal: J Cachexia Sarcopenia Muscle Date: 2022-04-03 Impact factor: 12.063